Iovance receives Australia approval for melanoma therapy Amtagvi

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. AWK
9. ACN
10. USO

Go back to Iovance receives Australia approval for melanoma therapy Amtagvi
(NASDAQ: IOVA) Delayed: 4.44 +0.38 (9.36%)
Previous Close $4.06    52 Week High $ 
Open $4.00    52 Week Low $ 
Day High $4.52    P/E N/A 
Day Low $3.99    EPS $ 
Volume 17,963,568